Promedicus (ASX:PME) shares rocket higher

There’s plenty to love about medical imaging software powerhouse Promedicus (ASX:PME). A founder led, highly profitable disruptor in a large and fast growing market, the business enjoys potent network effects and high switching costs. The balance sheet is rock-solid, costs are well managed and the business should continue to scale Continue Reading

Episode 7: Envirosuite, ooh Media and Rocket Lab

If there’s one thing that markets hate, it’s uncertainty. And with trade wars, political ructions and mixed economic signals — not to mention a host of company specific factors — it’s tempting for investors to sit on the sidelines until the outlook becomes clearer. The trouble is, if certainty is Continue Reading